Pharmafile Logo
Pharmafocus logo
Advanced Search

President trump

Showing 15 posts of 17 posts found.

8266471202_63a8f743a9_b

Pfizer, Sanofi and GlaxoSmithKline plan to increase US drug prices in 2020

January 2, 2020
Business Services Bernie Sanders, President trump, Presidential Election, Trump, Trump Drugs, drug prices

Multiple drugmakers, including Pfizer, Sanofi and GlaxoSmithKline, plan to increase US list prices on more than 200 drugs in the …

News
191101154915-stephen-hahn-fda-exlarge-169

Donald Trump nominates Dr Stephen Hahn as next FDA Commissioner

November 4, 2019
Medical Communications, Sales and Marketing Donald Trump, FDA, Ned Sharpless, President trump, Scott Gottlieb, Trump, US

The US FDA could be set to receive its next long-term Commissioner after the White House revealed President Donald Trump’s …

News
november_2018_cover

The November 2018 issue of Pharmafocus is available to read online now!

November 6, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, President trump, Trump, anti vaxxer, brexit, clinical trials, opioid crisis, opioids, pharma, vaccines

As the US continues to battle the demons in its healthcare system, Donald Trump looks like he may finally make …

News
shutterstock_138095450

Novartis follows Pfizer’s lead, pledges no price hikes in 2018

July 18, 2018
Research and Development, Sales and Marketing Novartis, Pfizer, President trump, Trump, US, pharma

Following US pharma giant Pfizer’s clash with President Donald Trump after it was called out on Twitter for hiking the …

News
shutterstock_254160583

Trump forces Pfizer to back down and delay price hikes until 2019

July 11, 2018
Research and Development, Sales and Marketing Alex Azar, Donald Trump, Ian Read, Pfizer, President trump, Trump, druig pricing, pharma

Trump bared his teeth, and it paid off. Following his call-out of Pfizer after the US pharma giant ignored the …

News
shutterstock_138095450

Unfazed by Trump, Pfizer hikes prices for 100 of its drugs

July 3, 2018
Manufacturing and Production, Sales and Marketing Pfizer, President trump, Trump, pharma, price hikes

After a campaign full of not-so-veiled threats directed at the pharma industry, and a presidency which has so far failed …

News
donald_j

Pharma unfazed by Trump price-reduction proposals

May 14, 2018
Medical Communications, Sales and Marketing PhRMA, President trump, biotech, drugs, pharma, pharmaceutical

President Trump’s speech on Friday afternoon had been long-anticipated, ever since he was elected and then hammered the pharma industry …

News

Novartis’ $1.2m payment to Trump’s lawyer raises more questions than answers

May 10, 2018
Medical Communications Essential Consultants, Michael Cohen, Novartis, President trump, Trump, biotech, drugs, pharma, pharmaceutical

Novartis payment to President Trump’s personal lawyer, Michael Cohen, had seemed fairly odd from the beginning – with many asking …

News
michael_cohen

Novartis caught in the Stormy Daniels affair, after huge payment to Trump’s lawyer

May 9, 2018
Medical Communications, Research and Development Cohen, Novartis, President trump, Trump, biotech, drugs, pharma, pharmaceutical

Novartis has suddenly found itself embroiled in the Stormy Daniels affair, after the lawyer representing her, Michael Avenatti, included the …

News

Trump’s drug pricing reforms lack bite

February 12, 2018
Sales and Marketing Drug pricing, President trump, Trump, biotech, drugs, pharma, pharmaceutical

President Trump’s rhetoric leading up to his election had the pharmaceutical industry very worried – his often quoted line about …

News
alex_azar_wwsg_photo_cropped

Trump nominee and ex-Lilly exec confirmed as US Health Secretary by Senate

January 25, 2018
Manufacturing and Production, Medical Communications, Sales and Marketing Alex Azar, Eli Lilly, President trump, Trump, US, pharma

Alex Azar, President’s Trump’s controversial pick for Health and Human Services Secretary (HHS), has been confirmed in the role after …

News
5440392565_4634fb9d24_z

Trump suggests he will declare opioid national emergency next week

October 17, 2017
Manufacturing and Production, Sales and Marketing President trump, Trump, biotech, drugs, pharma, pharmaceutical

Back in August, President Trump had suggested that the opioid epidemic that is ravaging the US would be declared a …

News
contraceptive-pills-849413_960_720

Trump sweeps away birth control coverage

October 9, 2017
Medical Communications, Sales and Marketing President trump, Trump, biotech, birth control, drugs, pharma, pharmaceutical

Part of Obama’s Affordable Care Act included the provision that employer-provided health insurance must cover birth control, President Trump has …

News
virginia-7592

Has Trump’s power over pharma come to an end after Charlottesville?

August 31, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Donald Trump, J&J, JJ, Kenneth Frazier, MSD, President trump, Trump, life sciences, medicine, pharma, pharmaceuticals, president

In a shock move that was to have deeply resonant consequences, MSD Chairman and Chief Executive Officer Kenneth Frazier announced …

Feature
pharmafocus_september_2017_cover

The September 2017 issue of Pharmafocus is now live!

August 30, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Cancer Research UK, MSD, Pharmafocus, President trump, Takeda, Trump, charlottesville, life sciences, oncology, pharmaceuticals, phatma

The September edition of Pharmafocus is now available – click here to read online.

News

Latest content

BactiVac funds development of bacterial vaccines to prevent infections against antimicrobial resistance

September 28, 2023

Avalyn Pharma raises $175m in Series C financing for inhalation therapies

September 28, 2023

NMD Pharma begins phase 2 trial for spinal muscular atrophy treatment

September 27, 2023

Alfasigma to acquire Intercept Pharmaceuticals for $19 per share

September 27, 2023

Regeneron and Sanofi’s sBLA for Dupixent accepted by FDA for priority review

September 26, 2023